Literature DB >> 14630822

Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

John C Wood1, J Michael Tyszka, Susan Carson, Marvin D Nelson, Thomas D Coates.   

Abstract

Cardiac T2* (magnetic resonance imaging relaxation parameter) is abnormally low in approximately 40% of adults with thalassemia major (TM), suggesting myocardial iron deposition, but it is unknown at what age this occurs. To address this question, we measured cardiac T2* and function in 19 young patients (aged 7-26 years) with TM as well as 17 patients receiving long-term transfusions for sickle cell anemia (SCA) matched for age, sex, and liver iron content. Cardiac T2* was normal in all of the SCA patients but was low (high iron) in 8 of 19 TM patients. Abnormal T2* was observed only in the TM patients receiving transfusions for 13 years or longer and was correlated with ferritin but not liver iron levels. Cardiac dysfunction was present in 3 of the 8 patients with low T2*. Cardiac T2* changes have a long latency relative to liver iron accumulation. Total transfusional burden is a significant independent risk factor for low cardiac T2* and may partially account for differences observed between patients with SCA and TM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630822     DOI: 10.1182/blood-2003-06-1919

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  104 in total

1.  Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload.

Authors:  Dudley J Pennell; John B Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi-Kong Li; Vip Viprakasit; Mohsen Saleh Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

Review 2.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

3.  Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate.

Authors:  Daniel Kim; Jens H Jensen; Ed X Wu; Li Feng; Wing-Yan Au; Jerry S Cheung; Shau-Yin Ha; Sujit S Sheth; Gary M Brittenham
Journal:  NMR Biomed       Date:  2010-12-28       Impact factor: 4.044

4.  Hemolysis-associated pulmonary hypertension in thalassemia.

Authors:  Claudia R Morris; Frans A Kuypers; Gregory J Kato; Lisa Lavrisha; Sandra Larkin; Titi Singer; Elliott P Vichinsky
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

5.  Improved R2* measurements in myocardial iron overload.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

Review 6.  Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions.

Authors:  Ellis J Neufeld
Journal:  Blood       Date:  2006-05-01       Impact factor: 22.113

7.  Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Authors:  Patrick B Walter; Ellen B Fung; David W Killilea; Qing Jiang; Mark Hudes; Jacqueline Madden; John Porter; Patricia Evans; Elliott Vichinsky; Paul Harmatz
Journal:  Br J Haematol       Date:  2006-10       Impact factor: 6.998

8.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

9.  Intensive chelation therapy in beta-thalassemia and possible adverse cardiac effects of desferrioxamine.

Authors:  Athanassios Aessopos; Maria Kati; Dimitrios Farmakis; Ekaterini Polonifi; Spyros Deftereos; Maria Tsironi
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

10.  Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias.

Authors:  Sarah Deborah Chirnomas; Marnix Geukes-Foppen; Kristen Barry; Jennifer Braunstein; Leslie A Kalish; Ellis J Neufeld; Andrew J Powell
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.